Tea polyphenols and their roles in cancer prevention and chemotherapy

International Journal of Molecular Sciences

Volumn 9, Issue 7, 2008, Pages 1196-1206

  Chen, Di ^a   Dou, Q Ping ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer prevention; Chemotherapy; Tea polyphenols

Indexed keywords

APIGENIN; BORTEZOMIB; CISPLATIN; CURCUMIN; DNA METHYLTRANSFERASE; DRUG METABOLITE; EPIGALLOCATECHIN GALLATE; FLAVONOID; FUMAGILLOL CHLOROACETYLCARBAMATE; GENISTEIN; GO Y016; GO Y030; GO Y031; KAEMPFEROL; LUTEOLIN; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PRODRUG; PROTEASOME; QUERCETIN; TETRAHYDROCURCUMIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; BREAST CANCER; BROCCOLI; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CARCINOGENESIS; CELERY; CELL STRAIN HCT116; CELL STRAIN HEPG2; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CANCER; DNA METHYLATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; DRUG SPECIFICITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; ENZYME INHIBITION; EXPERIMENTAL MOUSE; FRUIT; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; LEUKEMIA CELL LINE; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; NONHUMAN; ONION; OXIDATION; OXIDATIVE STRESS; PANCREAS CANCER; PARSLEY; PEPPER; PROSTATE ADENOCARCINOMA; REVIEW; SKIN CANCER; SOYBEAN; SQUAMOUS CELL CARCINOMA; STRUCTURE ACTIVITY RELATION; TEA; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL; VEGETABLE;

APIUM GRAVEOLENS VAR. DULCE; BRASSICA OLERACEA VAR. ITALICA; CURCUMA LONGA; PETROSELINUM CRISPUM;

EID: 48649104740     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms9071196     Document Type: Review

References (64)

1. Garcia, M.; Jemal, A.; Ward, E.M.; Center, M.M.; Hao, Y.; Siegel, R.L.; Thun, M.J. Global Cancer Facts & Figures 2007. The American Cancer Society: Atlanta, GA, USA, 2007.
2. Riboli, E.; Norat, T. Epidemiologic Evidence of the Protective Effect of Fruit and Vegetables on Cancer Risk. Am. J. Clin. Nutr. 2003, 78, 559S-569S.
3. Ross, J.A.; Kasum, C.M. Dietary Flavonoids: Bioavailability, Metabolic Effects, and Safety. Annu. Rev. Nutr. 2002, 22, 19-34.
4. Tadjalli-Mehr, K.; Becker, N.; Rahu, M.; Stengrevics, A.; Kurtinaitis, J.; Hakama, M. Randomized Trial with Fruits and Vegetables in Prevention of Cancer. Acta Oncol. 2003, 42, 287-293.
5. Temple, N.J.; Gladwin, K.K. Fruit, Vegetables, and the Prevention of Cancer: Research Challenges. Nutrition. 2003, 19, 467-470.
6. Mukhtar, H.; Ahmad, N. Cancer Chemoprevention: Future Holds in Multiple Agents. Toxicol. Appl. Pharmacol. 1999, 158, 207-210.
7. Adams, J. Development of the Proteasome Inhibitor PS-341. The Oncologist 2002, 7, 9-16.
8. Dou, Q.P.; Goldfarb, R.H. Bortezomib (Millennium Pharmaceuticals). IDrugs 2002, 5, 828-834.
9. Kane, R.C.; Farrell, A.T.; Sridhara, R.; Pazdur, R. United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma After One Prior Therapy. Clin. Cancer Res. 2006, 12, 2955-2960.
10. Hochstrasser, M. Ubiquitin, Proteasomes, and the Regulation of Intracellular Protein Degradation. Curr. Opin. Cell Biol. 1995, 7, 215-223.
11. Ciechanover, A. The Ubiquitin-Proteasome Proteolytic Pathway. Cell 1994, 79, 13-21.
12. Goldberg, A.L. Functions of the Proteasome: The Lysis at the End of the Tunnel. Science 1995, 268, 522-523.
13. Seemuller, E.; Lupas, A.; Stock, D.; Lowe, J.; Huber, R.; Baumeister, W. Proteasome from Thermoplasma Acidophilum: A Threonine Protease. Science 1995, 268, 579-582.
14. An, B.; Goldfarb, R.H.; Siman, R., Dou, Q.P. Novel Dipeptidyl Proteasome Inhibitors Overcome Bcl-2 Protective Function and Selectively Accumulate the Cyclin-Dependent Kinase Inhibitor p27 and Induce Apoptosis in Transformed, but not Normal, Human Fibroblasts. Cell Death Differ. 1998, 5, 1062-1075.
15. Lopes, U.G.; Erhardt, P.; Yao, R.; Cooper, G.M. p53-Dependent Induction of Apoptosis by Proteasome Inhibitors. J. Biol. Chem. 1997, 272, 12893-12896.
16. Nam, S.; Smith, D.M.; Dou, Q.P. Ester Bond-Containing Tea Polyphenols Potently Inhibit Proteasome Activity in vitro and in vivo. J. Biol. Chem. 2001, 276, 13322-13330.
17. Kazi, A.; Wang, Z.; Kumar, N.; Falsetti, S.C.; Chan, T.H.; Dou, Q.P. Structure-Activity Relationships of Synthetic Analogs of (-)-Epigallocatechin-3- Gallate as Proteasome Inhibitors. Anticancer Res. 2004, 24, 943-954.
18. Landis-Piwowar, K.R.; Kuhn, D.J.; Wan, S.B.; Chen, D.; Chan, T.H.; Dou, Q.P. Evaluation of Proteasome-Inhibitory and Apoptosis-Inducing Potencies of Novel (-)-EGCG Analogs and Their Prodrugs. Int. J. Mol. Med. 2005, 15, 735-742.
19. Kuhn, D.; Lam, W.H.; Kazi, A.; Daniel, KG.; Song, S.; Chow, L.M.; Chan, T.H.; Dou, Q.P. Synthetic Peracetate Tea Polyphenols as Potent Proteasome Inhibitors and Apoptosis Inducers in Human Cancer Cells. Front. Biosci. 2005, 10, 1010-1023.
20. Landis-Piwowar, K.R.; Huo, C.; Chen, D.; Milacic, V.; Shi, G.; Chan, T.H.; Dou, Q.P. A Novel Prodrug of the Green Tea Polyphenol (-)- Epigallocatechin-3-Gallate as a Potential Anticancer Agent. Cancer Res. 2007, 67, 4303-4310.
21. Feinberg, A.P.; Tycko, B. The History of Cancer Epigenetics. Nat. Rev. Cancer. 2004, 4, 143-153.
22. Esteller, M.; Risques, R.A.; Toyota, M.; Capella, G.; Moreno, V.; Peinado, M.A.; Baylin, S.B.; Herman, J.G. Promoter Hypermethylation of the DNA Repair Gene 0(6)-Methylguanine-DNA Methyltransferase Is Associated With the Presence of G:C to A:T Transition Mutations in p53 in Human Colorectal Tumorigenesis. Cancer Res. 2001, 61, 4689-4692.
23. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines. Cancer Res. 2003, 63, 7563-7570.
24. Yuasa, Y.; Nagasaki, H.; Akiyama, Y.; Sakai, H.; Nakajima, T.; Ohkura, Y.; Takizawa, T.; Koike, M.; Tani, M.; Iwai, T.; Sugihara, K.; Imai, K.; Nakachi, K. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis. 2005, 26, 193-200.
25. Cutler, R.G. Oxidative Stress Profiling: Part I. Its Potential Importance in the Optimization of Human Health. Ann. NY Acad. Sci. 2005, 1055, 93-135.
26. Cutler, R.G.; Plummer, J.; Chowdhury, K.; Heward, C. Oxidative Stress Profiling: Part II. Theory, Technology, and Practice. Ann. NY Acad. Sci. 2005, 1055, 136-158.
27. Mukhtar, H.; Ahmad, N. Mechanism of Cancer Chemopreventive Activity of Green Tea. P. Soc. Exp. Biol. Med. 1999, 220, 234-238.
28. Rah, D.K.; Han, D.W.; Baek, H.S.; Hyon, S.H.; Park, J.C. Prevention of Reactive Oxygen Species-induced Oxidative Stress in Human Microvascular Endothelial Cells by Green Tea Polyphenol. Toxicol. Lett. 2005, 155, 269-275.
29. Coimbra, S.; Castro, E.; Rocha-Pereira, P.; Rebelo, I.; Rocha, S.; Santos-Silva, A. The Effect of Green Tea in Oxidative Stress. Clin. Nutr. 2006, 25, 790-796.
30. Sung, H.; Nah, J.; Chun, S.; Park, H.; Yang, S.E.; Min, W.K. In vivo Antioxidant Effect of Green Tea. Eur. J. Clin. Nutr. 2000, 54, 527-529.
31. Cheynier, V. Polyphenols in Foods Are More Complex Than Often Thought. Am. J. Clin. Nutr. 2005, 81, 223S-229S.
32. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary Polyphenols and the Prevention of Diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
33. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food Sources and Bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
34. Fotsis, T.; Pepper, M.; Adlercreutz, H.; Hase, T.; Montesano, R.; Schweigerer, L. Genistein, a Dietary Ingested Isoflavonoid, Inhibits Cell Proliferation and in vitro Angiogenesis. J. Nutr. 1995, 125, 790S-797S.
35. Barnes, S. Effect of Genistein on in vitro and in vivo Models of Cancer. J. Nutr. 1995, 125, 777S-783S.
36. Lamartiniere, C.A.; Cotroneo, M.S.; Fritz, W.A.; Wang, J.; Mentor-Marcel, R.; Elgavish, A. Genistein Chemoprevention: Timing and Mechanisms of Action in Murine Mammary and Prostate. J. Nutr. 2002, 132, 552S-558S.
37. Wang, J.; Eltoum, I.E.; Lamartiniere, C.A. Genistein Alters Growth Factor Signaling in Transgenic Prostate Model (TRAMP). Mol. Cell Endocrinol. 2004, 219, 171-180.
38. Santell, R.C.; Kieu, N.; Helferich, W.G Genistein Inhibits Growth of Estrogen-Independent Human Breast Cancer Cells in Culture but Not in Athymic Mice. J. Nutr. 2000, 130, 1665-1669.
39. Constantinou, A.I.; Krygier, A.E.; Mehta, R.R. Genistein Induces Maturation of Cultured Human Breast Cancer Cells and Prevents Tumor Growth in Nude Mice. Am. J. Clin. Nutr. 1998, 68, 1426S-1430S.
40. Wei, H.; Bowen, R.; Zhang, X.; Lebwohl, M. Isoflavone Genistein Inhibits the Initiation and Promotion of Two-Stage Skin Carcinogenesis in Mice. Carcinogenesis 1998, 19, 1509-1514.
41. Guo, T.L.; Chi, R.P.; Hernandez, D.M.; Auttachoat, W.; Zheng, J.F. Decreased 7,12-Dimethylbenz[a]Anthracene-Induced Carcinogenesis Coincides with the Induction of Antitumor Immunities in Adult Female B6C3F1 Mice Pretreated with Genistein. Carcinogenesis 2007, 28, 2560-2566.
42. Miean, K.H.; Mohamed, S.; Flavonoid (Myricetin, Quercetin, Kaempferol, Luteolin, and Apigenin) Content of Edible Tropical Plants. J. Agric. Food Chem. 2001, 49, 3106-3112.
43. Chen, D.; Chen, M.S.; Cui, Q.C.; Yang, H.; Dou, Q.P. Structure- Proteasome-Inhibitory Activity Relationships of Dietary Flavonoids in Human Cancer cells. Front. Biosci. 2007, 12, 1935-1945.
44. Chen, D.; Daniel, K.G.; Chen, M.S.; Kuhn, D.J.; Landis-Piwowar, K.R.; Dou, Q.P. Dietary Flavonoids as Proteasome Inhibitors and Apoptosis Inducers in Human Leukemia Cells. Biochem. Pharmacol. 2005, 69, 1421-1432.
45. Chen, D.; Landis-Piwowar, K.R.; Chen, M.S.; Dou, Q.P. Inhibition of Proteasome Activity by the Dietary Flavonoid Apigenin Is Associated With Growth Inhibition in Cultured Breast Cancer Cells and Xenografts. Breast Cancer Res. 2007, 9, R80.
46. Shukla, S.; Gupta, S. Molecular Targets for Apigenin-Induced Cell Cycle Arrest and Apoptosis in Prostate Cancer Cell Xenograft. Mol. Cancer Ther. 2006, 5, 843-852.
47. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer Potential of Curcumin: Preclinical and Clinical Studies. Anticancer Res. 2003, 23, 363-398.
48. Balasubramanyam, M.; Koteswari, A.A.; Kumar, R.S.; Monickaraj, S.F.; Maheswari, J.U.; Mohan, V.; Curcumin-Induced Inhibition of Cellular Reactive Oxygen Species Generation: Novel Therapeutic Implications. J. Biosci. 2003, 28, 715-721.
49. Woo, H.M.; Kang, J.H.; Kawada, T.; Yoo, H.; Sung, M.K; Yu, R Active Spice-Derived Components Can Inhibit Inflammatory Responses of Adipose Tissue in Obesity by Suppressing Inflammatory Actions of Macrophages and Release of Monocyte Chemoattractant Protein-1 from Adipocytes. Life Sci. 2007, 80, 926-931.
50. Aggarwal, S.; Takada, Y.; Singh, S.; Myers, J.N.; Aggarwal, B.B. Inhibition of Growth and Survival of Human Head and Neck Squamous Cell Carcinoma Cells by Curcumin via Modulation of Nuclear Factor-kappaB Signaling. Int. J. Cancer 2004, 111, 679-692.
51. Mohan, R.; Sivak, J.; Ashton, P.; Russo, LA.; Pham, B.Q.; Kasahara, N.; Raizman, M.B.; Fini, M.E. Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B. J. Biol. Chem. 2000, 275, 10405-10412.
52. Yoysungnoen, P.; Wirachwong, P.; Bhattarakosol, P.; Niirni, H.; Patumraj, S. Effects of Curcumin on Tumor Angiogenesis and Biomarkers, COX-2 and VEGF, in Hepatocellular Carcinoma Cell-Implanted Nude Mice. Clin. Hemorheol. Microcirc. 2006, 34, 109-115.
53. LoTempio, M.M.; Veena, M.S.; Steele, H.L.; Ramamurthy, B.; Ramalingam, T.S.; Cohen, A.N.; Chakrabarti, R.; Srivatsan, E.S.; Wang, M.B. Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma. Clin. Cancer Res. 2005, 11, 6994-7002.
54. Tonnesen, H.H.; Karlsen, J. Studies on Curcumin and Curcuminoids. VI. Kinetics of Curcumin Degradation in Aqueous Solution. Z. Lebensm. Unters. Forsch. 1985, 180, 402-404.
55. Wang, Y.J.; Pan, M.H.; Cheng, A.L.; Lin, L.I.; Ho, Y.S.; Hsieh, C.Y.; Lin, J.K. Stability of Curcumin in Buffer Solutions and Characterization of Its Degradation Products. J. Pharm. Biomed. Anal. 1997, 15, 1867-1876.
56. Pan, M.H.; Huang, T.M., Lin, J.K.; Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice. Drug Metab. Dispos. 1999, 27, 486-494.
57. Yoysungnoen, P.; Wirachwong, P.; Changtam, C.; Suksamrarn, A.; Patumraj, S. Anti-Cancer and Anti-Angiogenic Effects of Curcumin and Tetrahydrocurcumin on Implanted Hepatocellular Carcinoma in Nude Mice. World J. Gastroenterol. 2008, 14, 2003-2009.
58. Cheng, A.L.; Hsu, C.H.; Lin, J.K.; Hsu, M.M.; Ho, Y.F.; Shen, T.S.; Ko, J.Y.; Lin, J.T.; Lin, B.R.; Ming-Shiang, W.; Yu, H.S.; Jee, S.H.; Chen, G.S.; Chen, T.M.; Chen, C.A.; Lai, M.K.; Pu, Y.S.; Pan, M.H.; Wang, Y.J.; Tsai, C.C.; Hsieh, C.Y. Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions. Anticancer Res. 2001, 21, 2895-2900.
59. Dhillon N.; Wolff, R.A.; Abbruzzese, J.L.; Hong, D.S.; Camacho, L.H.; Li, L.; Braiteh, F.S.; Kurzrock, R.; Phase II Clinical Trial of Curcumin in Patients with Advanced Pancreatic Cancer. J. Clin. Oncol. 2006, 24, 14151.
60. Sharma, R.A.; Euden, S.A.; Platton, S.L. et al. Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance. Clin. Cancer Res 2004, 10, 6847-6854.
61. Garcea, G.; Berry, D.P.; Jones, D.J. et al. Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and Their Pharmacodynamic Consequences. Cancer Epidemiol Biomarkers Prev. 2005, 14, 120-125.
62. Adams, B.K.; Ferstl, E.M.; Davis, M.C.; et al. Synthesis and Biological Evaluation of Novel Curcumin Analogs as Anti-Cancer and Anti-Angiogenesis Agents. Bioorg. Med. Chem. 2004, 12, 3871-3883.
63. Ohori, H.; Yamakoshi, H.; Tomizawa, M. et al. Synthesis and Biological Analysis of New Curcumin Analogues Bearing an Enhanced Potential for the Medicinal Treatment of Cancer. Mol. Cancer Ther. 2006, 5, 2563-2571.
64. Landis-Piwowar, K.R.; Huo, C.; Chen, D. et al. A Novel Prodrug of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate as a Potential Anticancer Agent. Cancer Res. 2007, 67, 4303-4310.